Our results revealed an increase in the m6A-binding ability of YTHDF2, and the KD of YTHDF2 noticeably increased the stability and expression of c-Myc and E2F1 transcripts in breast cancer cells. The gene discussed is YTHDF2; the disease is breast carcinoma.